DIAPH3 and pancreatic neoplasm: We further analysed the data in the TCGA database UALCAN and confirmed the up‐regulated expression of DIAPH3 in pancreatic cancer, and this up‐regulation multiple gradually increased along with the progression of pancreatic cancer (Figure 1B).